Patent · US Active

Antibody against human cardiac troponin i and use thereof

US12173056B2 · kind B2 · utility

0Cited by

0References

19Claims

0Family size

Assignee

Fapon Biotech Inc. · CN

Inventors

Peng Cui · Suwon-si, KR
Zhiqiang He · Nanhu, CN
Yuan Meng · Rochester, US
Dongmei ZHONG · Dongguan, CN

Key dates

Filing date	Sep 27, 2019
Grant date	Dec 24, 2024
Priority date	—
Expiry date	Feb 9, 2042

Classification

Technology area (CPC G)Physics
CPC primaryG01N2800/324
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Disclosed is an isolated binding protein including a cardiac troponin I (cTnI) antigen binding domain, and preparation and a use and the like of the binding protein. The antigen binding domain includes at least one complementarity determining region selected from an amino acid sequence defined in this article, or has at least 80% sequence identity with the complementarity determining region of the amino acid sequence and has KD≤9.96×10−8 mol/L affinity with cTnI. The binding protein may be used in the detection field of the cTnI protein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.